EFMC-ASMC'19

EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry

 Athens, Greece    September 1-5, 2019

Opening Lecture

Opening Lecture
The Art and Science of Total Synthesis and Its Impact on Biology and Medicine: From the Fundamentals to the Translational (T01)

Prof. K.C. NICOLAOU
Prof. K.C. NICOLAOU
RICE UNIVERSITY, Houston, United States
Read more

Invited Speakers

Flow Chemistry and photochemistry as a Tool for Drug Discovery (T23)

Dr Jesus ALCAZAR
Dr Jesus ALCAZAR
J&J PHARMACEUTICAL RESEARCH AND DEVELOPMENT, Toledo, Spain
Read more

Awareness of PAINS (Pan Assay Interference Compounds) can Accelerate the Drug Discovery Process (T14)

Prof. Jonathan BAELL
Prof. Jonathan BAELL
MONASH UNIVERSITY, Parkville, Australia
Read more

Artificial Intelligence in ADMET Modeling and Compound Profiling (T15)

Dr Karl-Heinz BARINGHAUS
Dr Karl-Heinz BARINGHAUS
SANOFI, Frankfurt, Germany
Read more

TLR7/8 Antagonists: from Screening to in vivo Potency (T26)

Dr Claudia BETSCHART
Dr Claudia BETSCHART
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
Read more

RNA Therapeutics: New Chemical Modalities Becoming a Therapeutic Reality (T25)

Dr Konrad BLEICHER
Dr Konrad BLEICHER
F.HOFFMANN-LA ROCHE LTD, Basel, Switzerland
Read more

Sustainable by Design Anti-Trypanosomatid Small Molecules: an Aspirational Goal for Medicinal Chemistry (T16)

Prof. Maria Laura BOLOGNESI
Prof. Maria Laura BOLOGNESI
UNIVERSITY OF BOLOGNA, Bologna, Italy
Read more

Catalytic Chirality Generation: New Strategies for Organic Synthesis (T06)

Prof. John BOWER
Prof. John BOWER
UNIVERSITY OF BRISTOL, Bristol, United Kingdom
Read more

Nature’s Medicine Chest: Opportunities for Synthesis and Drug Discovery (T02)

Prof. Margaret Anne BRIMBLE
Prof. Margaret Anne BRIMBLE
THE UNIVERSITY OF AUCKLAND, Auckland, New Zealand
Read more

Allosteric Activation of a Master Metabolic Regulator AMPK: Drug Discovery Opportunities and Challenges (T27)

Dr Kimberly CAMERON
Dr Kimberly CAMERON
PFIZER, Cambridge, United States
Read more

Design and Synthesis of Chemical Probes for Bromodomains (T10)

Prof. Stuart CONWAY
Prof. Stuart CONWAY
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

You Get What You Start With - Next Generation EGFR TKIs (T24)

Dr Harald ENGELHARDT
Dr Harald ENGELHARDT
BOEHRINGER-INGELHEIM, Vienna, Austria
Read more

Artificial Intelligence in de Novo Molecular Design (T17)

Dr Ola ENGKVIST
Dr Ola ENGKVIST
ASTRAZENECA, Mölndal, Sweden
Read more

Design and Implementation of de Novo Biosynthetic Cascades (T20)

Prof. Sabine FLITSCH
Prof. Sabine FLITSCH
UNIVERSITY OF MANCHESTER, Manchester, United Kingdom
Read more

Catalysis for Total Synthesis (T21)

Prof. Alois FÜRSTNER
Prof. Alois FÜRSTNER
MAX PLANCK INSTITUT FUR KOHLENFORSCHUNG, Muelheim an der Ruhr, Germany
Read more

Amides and Chemical Education as Vehicles for Innovation (T18)

Prof. Neil GARG
Prof. Neil GARG
UNIVERSITY OF CALIFORNIA, Los Angeles, United States
Read more

A Chemical Approach to Map Protein Interactions at the Cell Surface (T12)

Dr Erik HETT
Dr Erik HETT
MERCK EXPLORATORY SCIENCE CENTER, Boston, United States
Read more

Title to be announced (T11)

Dr Kim HUARD
Dr Kim HUARD
GENENTECH, San Francisco, United States
Read more

Practical Heteroatom- and Group-Transfer Reactions (T09)

Dr Laszlo KURTI
Dr Laszlo KURTI
RICE UNIVERSITY, Houston, United States
Read more

Discovery of AZD5718, a Novel 5-lipoxygenase Activating Protein (FLAP) Inhibitor (T19)

Dr Malin LEMURELL
Dr Malin LEMURELL
ASTRAZENECA, Mölndal, Sweden
Read more

Photoinduced Assembly of C–N Bonds (T08)

Dr Daniele LEONORI
Dr Daniele LEONORI
UNIVERSITY OF MANCHESTER, Manchester, United Kingdom
Read more

Discovery of First in Class, Orally Bioavailable p300/CBP HAT Domain Inhibitors (T04)

Dr Michael MICHAELIDES
Dr Michael MICHAELIDES
ABBVIE, North Chicago, United States
Read more

Drug Discovery in Academia (T03)

Prof. Oliver PLETTENBURG
Prof. Oliver PLETTENBURG
LEIBNIZ UNIVERSITY HANNOVER, Hannover, Germany
Read more

From Fragments to Antibody Drug Conjugates in Emerging Oncology Targeted Therapies (T13)

Dr Laurent SCHIO
Dr Laurent SCHIO
SANOFI, Vitry sur Seine, France
Read more

Synthesis of Versatile Intermediates Through Copper Catalysis (T07)

Prof. Mariola TORTOSA
Prof. Mariola TORTOSA
AUTONOMOUS UNIVERSITY OF MADRID, Madrid, Spain
Read more

Development and Application in Flow of Sustainable Synthetic Methodologies that Use Singlet Oxygen as Green Oxidant and Cascade Reaction Facilitator (T22)

Prof. Georgios VASSILIKOGIANNAKIS
Prof. Georgios VASSILIKOGIANNAKIS
UNIVERSITY OF CRETE, Heraklion, Greece
Read more

Novel Bacterial Topoisomerase Inhibitors (NBTI) with Potent Gram-Negative Activity (T05)

Dr Cornelia ZUMBRUNN
Dr Cornelia ZUMBRUNN
IDORSIA PHARMACEUTICALS, Allschwil, Switzerland
Read more